| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Grant PJ | |
| P2860 | cites work | Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 |
| Atherosclerosis | Q24644573 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. | Q51553762 | ||
| Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. | Q51558893 | ||
| Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). | Q51564820 | ||
| Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. | Q51599356 | ||
| Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. | Q51608271 | ||
| Hypertriglyceridaemia and hypercoagulability | Q51647241 | ||
| Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. | Q52430703 | ||
| Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. | Q52535925 | ||
| Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects. | Q52860018 | ||
| Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. | Q54028814 | ||
| Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells. | Q54131738 | ||
| Features of syndrome X in first-degree relatives of NIDDM patients. | Q54169672 | ||
| Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. | Q54314674 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q55921416 | ||
| Atherogenic lipoproteins and release of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells | Q57398974 | ||
| Effect of intensive glycaemic control on fibrinogen plasma concentrations in patients with Type II diabetes mellitus. Relation with β-fibrinogen genotype | Q58829291 | ||
| Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians | Q28241514 | ||
| Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome | Q30954731 | ||
| Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. | Q31809656 | ||
| Platelet dysfunction in type 2 diabetes | Q34319534 | ||
| Pathophysiology of hypertension and endothelial dysfunction in patients with diabetes mellitus | Q34451786 | ||
| The fibrinolysis system: regulation of activity and physiologic functions of its main components | Q34527556 | ||
| Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function | Q34548597 | ||
| Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. | Q34752127 | ||
| Role of endothelial dysfunction in insulin resistance | Q35212546 | ||
| Insulin resistance, inflammation, and the prediabetic state | Q35212549 | ||
| C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? | Q37878667 | ||
| Atherosclerosis and the coagulation system | Q38713518 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Mediators produced by the endothelial cell | Q39549249 | ||
| Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein | Q40302035 | ||
| Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature | Q40904739 | ||
| Fibrin and atherogenesis — A hypothesis | Q41030793 | ||
| Endothelial dysfunction: cause of the insulin resistance syndrome | Q41585836 | ||
| Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature | Q41812180 | ||
| Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. | Q42453569 | ||
| Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells | Q42481905 | ||
| In vivo effect of insulin on intracellular calcium concentrations: relation to insulin resistance | Q42527358 | ||
| In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. | Q42536696 | ||
| Association between coagulation factors VII and X with triglyceride rich lipoproteins | Q42842347 | ||
| Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. | Q43588414 | ||
| Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction | Q43746731 | ||
| Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. | Q43787195 | ||
| Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity | Q43852839 | ||
| Perinatal mortality in triplet births in Japan: time trends and factors influencing mortality | Q43923657 | ||
| Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study | Q43935468 | ||
| A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension | Q43980466 | ||
| Prognostic value of coronary vascular endothelial dysfunction | Q44090667 | ||
| Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition | Q44134035 | ||
| Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus | Q44434968 | ||
| Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. | Q44729331 | ||
| Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study | Q44734148 | ||
| Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction | Q44758541 | ||
| Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults | Q44842276 | ||
| Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus | Q45334917 | ||
| The influence of type 2 diabetes on fibrin structure and function | Q46466743 | ||
| Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus | Q46991176 | ||
| Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects | Q47212016 | ||
| Genetics of fibrin clot structure: a twin study. | Q47398324 | ||
| Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. | Q51003131 | ||
| Plasma fibrinogen in NIDDM: the Rotterdam study. | Q51021585 | ||
| Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. | Q51496229 | ||
| Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. | Q51501073 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 157-172 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Journal of Internal Medicine | Q6295387 |
| P1476 | title | Diabetes mellitus as a prothrombotic condition | |
| P478 | volume | 262 |
| Q56770452 | Q56770452 |
| Q97084227 | A Novel Indicator Predicts 2019 Novel Coronavirus Infection in Subjects with Diabetes |
| Q28483360 | A high red blood cell distribution width predicts failure of arteriovenous fistula |
| Q52844970 | A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. |
| Q35620111 | A prospective study of the associations between treated diabetes and cancer outcomes |
| Q41847786 | A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles |
| Q55250288 | APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats. |
| Q35293080 | Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events |
| Q46361381 | Acute cigarette smoke exposure reduces clot lysis -- association between altered fibrin architecture and the response to t-PA |
| Q43237787 | Acute effect of a high-carbohydrate low-fat meal on platelet aggregation |
| Q35460015 | Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies |
| Q92140401 | Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients |
| Q34461796 | Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus |
| Q33709160 | Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes. |
| Q54982064 | CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology. |
| Q35603084 | Calprotectin and platelet aggregation in patients with stable coronary artery disease |
| Q30446865 | Cardiometabolic risk management in type 2 diabetes and obesity |
| Q33602366 | Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008 |
| Q30356292 | Colour Doppler Evaluation of Extracranial Carotid Artery in Patients Presenting with Acute Ischemic Stroke and Correlation with Various Risk Factors. |
| Q58229736 | Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology |
| Q38793134 | Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. |
| Q42021514 | Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I |
| Q28743200 | Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values |
| Q37167506 | Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization |
| Q34830905 | Diabetes-related microvascular and macrovascular diseases in the physical therapy setting |
| Q33602359 | Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome |
| Q36109889 | Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome |
| Q88686866 | Does diabetes type increase the odds of venous thromboembolism following traumatic injury? |
| Q33789283 | Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activity |
| Q37763811 | Effect of omega-3 fish oil on cardiovascular risk in diabetes. |
| Q53702846 | Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients. |
| Q33760007 | Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel |
| Q64227865 | Effects of blood flow restriction exercise on hemostasis: a systematic review of randomized and non-randomized trials |
| Q44607709 | Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes |
| Q38243854 | Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures. |
| Q44252720 | Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction |
| Q35184652 | Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD). |
| Q41627248 | Evaluation of the Antithrombotic Effects of Rivaroxaban and Apixaban Using the Total Thrombus-Formation Analysis System®: In Vitro and Ex Vivo Studies |
| Q41377815 | Evidence for a Hypercoagulable State in Women With Ovarian Endometriomas |
| Q35781270 | Family history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks |
| Q93027926 | Fatal Pulmonary Thromboembolism in Patients with Diabetic Ketoacidosis: A Seven-Case Series and Review of the Literature |
| Q55372718 | Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography. |
| Q36758419 | Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets |
| Q61448814 | Functional and Structural Changes of the Blood-Nerve-Barrier in Diabetic Neuropathy |
| Q93384640 | Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study |
| Q83537187 | Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators |
| Q55383484 | Hemostatic state augmented with platelet indices among Sudanese diabetic septic foot. |
| Q33834001 | Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levels |
| Q37843935 | Higher titers of anti-Chlamydia pneumoniae IgG in diabetic retinopathy: a cross-sectional study |
| Q46053500 | How to manage hyperglycemia in an acute coronary syndrome patient |
| Q36113661 | Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats |
| Q36807512 | Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome |
| Q37759238 | Hyperglycemia: a prothrombotic factor? |
| Q36518566 | Impact of CHADS(2) Score on Neurological Severity and Long-Term Outcome in Atrial Fibrillation-Related Ischemic Stroke |
| Q42803524 | Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes |
| Q35142897 | Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice |
| Q91754378 | In vitro characterization of sonothrombolysis and echocontrast agents to treat ischemic stroke |
| Q91594521 | Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosis |
| Q33931418 | Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers |
| Q51321728 | Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity. |
| Q41951212 | Insulin, insulin resistance, and platelet signaling in diabetes |
| Q58579298 | Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review |
| Q92446461 | Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control |
| Q38603046 | Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities. |
| Q36555722 | Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment |
| Q37793877 | Novel mechanisms of endothelial dysfunction in diabetes |
| Q34927182 | Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients |
| Q37923882 | Pathogenesis of postoperative adhesion formation |
| Q38936026 | Pathophysiology of peripheral arterial disease in diabetes mellitus |
| Q37017506 | Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases |
| Q35905154 | Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies. |
| Q86519442 | Platelet activity in Chinese obese adolescents with and without insulin resistance |
| Q46358660 | Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation |
| Q43260146 | Platelets of type 2 diabetic patients are characterized by high ATP content and low mitochondrial membrane potential |
| Q33751641 | Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. |
| Q40772245 | Preadmission use of selective serotonin reuptake inhibitors and short-term mortality in diabetic patients hospitalized due to stroke |
| Q51371683 | Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study. |
| Q38455443 | Predisposing factors to post-operative adhesion development |
| Q35864765 | Previous gestational diabetes mellitus and markers of cardiovascular risk |
| Q92140492 | Principal Component Analysis on Recurrent Venous Thromboembolism |
| Q50939738 | Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training. |
| Q57044283 | Quantifying Platelet Margination in Diabetic Blood Flow |
| Q28611473 | Recurrence of Subdural Haematoma in a Population-Based Cohort - Risks and Predictive Factors |
| Q37462316 | Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives |
| Q85040740 | Review article: Coagulation and fibrinolysis in diabetes |
| Q34988616 | Risk factors for venous and arterial thrombosis |
| Q37612236 | Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study. |
| Q37269401 | Role of IGF-1 in glucose regulation and cardiovascular disease |
| Q43080336 | Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis |
| Q58788728 | Synergistic Integration of Laboratory and Numerical Approaches in Studies of the Biomechanics of Diseased Red Blood Cells |
| Q53320932 | The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population. |
| Q58886149 | The incidence of diabetes mellitus following pulmonary embolism: a retrospective cohort study |
| Q35827581 | The interactions between hemostasis and resistance training: a review |
| Q38261764 | The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). |
| Q37775818 | Therapeutic potential of plasminogen activator inhibitor-1 inhibitors |
| Q36612276 | Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint |
| Q64239248 | Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease |
| Q34404150 | Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q38613753 | Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population |
| Q34181381 | Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management |
| Q37707267 | Urinary biomarkers involved in type 2 diabetes: a review. |
| Q28475613 | Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology |
| Q30390876 | Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach |
| Q38392999 | What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers. |
| Q84108139 | [Update on diabetic macroangiopathy] |
Search more.